It’s time to say goodbye to summer and settle into days with a little more structure (and a little less humidity). It’s also Childhood Cancer Awareness month, a special time to raise awareness for pediatric cancer research and recognize the researchers who work toward discovering causes and developing treatments. In this week’s research news roundup, learn how scientists in our Cancer Center contributed to the approval of a new cancer drug to treat solid and brain tumors, join us in welcoming our new Chief of Infectious Diseases, learn about new discoveries into stress resilience, and more.
Tag Archive: Seema Bhatnagar
In this week’s news roundup, a Children's Hospital of Philadelphia researcher is recognized for her work to improve clinical effectiveness for children with endocrine-related diseases, and Center for Autism scientists present findings to the international autism research community.
Other highlights include an investigation of the effects of the microbiome on the brain that could lead to novel treatments for psychiatric conditions, a look into Google searches as a mechanism to offer more tailored support and education to families with children newly diagnosed with cancer, and a funding boost for telehealth research. In addition, the CHOP-based Pennsylvania Pediatric Medical Device Consortium announced its latest seed grants to support the creation and development of medical devices designed for children.
As the new year approaches, we look back with gratitude for yet another year packed with scientific breakthroughs in children’s health. Continuing a remarkable run for personalized gene therapies, 2018 marked the European Commission’s approval of two gene therapies pioneered at Children’s Hospital of Philadelphia and the University of Pennsylvania, as patients in the European Union (EU) may now be treated with chimeric antigen receptor (CAR)-T cell therapy for aggressive forms of leukemia, and the very first gene therapy developed for inherited blindness.
As part of a three-part Q&A series on Cornerstone, we’re learning more about the newest scholars of the Children’s Hospital of Philadelphia Postdoctoral Fellowship for Academic Diversity, a program that aims to expand our community of researchers from unique backgrounds and academic experiences. Central to our breakthroughs at CHOP, diversity allows our investigators to collaborate and confront pediatric problems from a variety of perspectives. In this series, we let each of our fellows tell their own stories, touching on everything from what diversity in research means to them to the exciting projects they have underway.
What’s going on inside our bodies and brains when we respond to stress? Previously, we covered research into powerful little neuropeptides called orexins that may help regulate an individual’s vulnerability to stress. Now, we dug into fresh research from the lab of Seema Bhatnagar, PhD, an associate professor in the division of Stress Neurobiology at Children’s Hospital of Philadelphia, and conducted by Laura Grafe, PhD, a postdoctoral fellow.